The Recall Desk

Manufacturer

Watson Laboratories Inc

22 recalls in our database name Watson Laboratories Inc as the manufacturing or recalling firm.

What the numbers show

Total
22
Critical
0
Severe
6
Most recent
2014-02-05

Of the 22 recalls from Watson Laboratories Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 6 (27%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–22 of 22

  • ModerateFDA (Drugs)·D-1053-2014·2014-02-05

    Watson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets

    Watson Laboratories is recalling 717 bottles of Hydrocodone Bitartrate and Acetaminophen tablets because the product contains broken tablets.

    Product
    Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by Watson Laboratories, Inc., Corona, CA 92880. Distributed by: Watson Pharma, Inc. NDC: 00591-0517-01.
    Category
    Drug
    Distribution
    10 states
  • SevereFDA (Drugs)·D-397-2014·2014-01-15

    Watson Recalls Carisoprodol Tablets Due to Metal Particulates

    Watson Laboratories is recalling 4,439 bottles of Carisoprodol Tablets because metal particulates were visually observed in the tablets.

    Product
    Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA. Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-66360-001·2013-10-16

    Watson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage

    Watson Laboratories is recalling Next Choice emergency contraceptive tablets because they may break when pushed through the packaging.

    Product
    Next Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDC 52544-287-54), Manufactured by Watson Laboratories Inc, 132 Business Center Drive, Corona, CA 92880.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-66251-001·2013-10-09

    Watson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination

    Watson Laboratories is recalling Oxycodone and Acetaminophen Tablets because foreign tablets were found in a sealed bottle.

    Product
    Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by: Watson Laboratories, Inc. Corona, CA 92880 USA, NDC 0591-0825-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1061-2013·2013-09-25

    Watson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals

    Watson Laboratories is recalling 875 bottles of Hydrocodone Bitartrate and Acetaminophen Tablets because defective bottles may have improperly seated tamper-evident seals.

    Product
    Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Count Bottle, Manufactured by: Watson Laboratories, Inc, Cocona, CA 92880, NDC 0591-2611-05.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-823-2013·2013-07-31

    Watson Recalls Oxycodone and Acetaminophen Capsules Due to Low Potency

    Watson Laboratories is recalling two lots of Oxycodone and Acetaminophen Capsules because the oxycodone content was found to be below specification at expiry.

    Product
    Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bottle (NDC 0591-0737-05), Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA92880.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-203-2013·2013-03-27

    Watson Recalls Meprobamate Tablets Due to Impurity Specification Failure

    Watson Laboratories is recalling meprobamate 200 mg tablets because an impurity, diphenyl sulfone, exceeded specification limits.

    Product
    Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 9591-5239-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-204-2013·2013-03-27

    Watson Recalls Meprobamate Tablets Due to Impurity Failure

    Watson Laboratories is recalling meprobamate 400 mg tablets because an impurity, diphenyl sulfone, exceeded specification limits.

    Product
    Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 0591-5238-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-205-2013·2013-03-27

    Watson Recalls Zarah Oral Contraceptive Tablets Due to Breakage

    Watson Laboratories is recalling Zarah oral contraceptive tablets because they may break while being pushed through the blister pack.

    Product
    ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by: Watson Laboratories, Inc., Corona, CA 92880. USA; Distributed by: Watson Pharma, Inc., Corona, CA 92880 USA. NDC 52544-981-31 Carton; NDC 52544-981-28
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-094-2013·2012-12-26

    Watson Recalls Caziant Tablets Due to Out-of-Specification Impurities

    Watson Laboratories is recalling Caziant tablets because out-of-specification results were obtained for a known impurity.

    Product
    Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Wa
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-058-2013·2012-11-28

    Watson Recalls Hydrocodone and Acetaminophen Tablets Due to Superpotent Risk

    Watson Laboratories is recalling specific lots of Hydrocodone Bitartrate and Acetaminophen tablets because they may be oversized and superpotent.

    Product
    Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 00591-0540-05.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-017-2013·2012-10-31

    Watson Recalls Necon 1/35-28 Tablets Due to Potential Cross-Contamination

    Watson Laboratories is recalling Necon 1/35-28 tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ). The recall covers 6,466 cartons distributed nationwide and in Puerto Rico.

    Product
    Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Pharma, Inc., A subsidiary of Watson Pharmaceuticals, Inc., Corona, CA 92880 U
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-016-2013·2012-10-31

    Watson Recalls Necon 10/11 Tablets Due to Potential HCTZ Contamination

    Watson Laboratories is recalling specific lots of Necon 10/11 oral contraceptives because they may contain trace amounts of Hydrochlorothiazide (HCTZ).

    Product
    Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/35 mcg, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-015-2013·2012-10-31

    Watson Recalls Zenchent Tablets Due to Potential Hydrochlorothiazide Contamination

    Watson Laboratories is recalling Zenchent tablets because certain lots may be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).

    Product
    Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0.035 mg, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc., Corona, CA 928
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-014-2013·2012-10-31

    Watson Recalls Lutera Tablets Due to Potential Hydrochlorothiazide Contamination

    Watson Laboratories is recalling specific lots of Lutera tablets because they may contain trace amounts of Hydrochlorothiazide (HCTZ).

    Product
    Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0.1 mg/0.02 mg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc., Pa
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-013-2013·2012-10-31

    Watson Recalls Zovia Tablets Due to Potential Cross-Contamination

    Watson Laboratories is recalling Zovia tablets because certain lots may contain trace amounts of Hydrochlorothiazide (HCTZ) due to cross-contamination.

    Product
    Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispenser packaged in 6 Tablet Dispensers per carton, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880 USA; Distributed by: Watson Pharma, Inc.;
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1436-2012·2012-08-08

    Watson Recalls Caziant Tablets Due to High Impurity Levels

    Watson Laboratories is recalling Caziant tablets because high levels of impurities were detected. Consumers should stop using the product and contact their healthcare provider.

    Product
    Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Wa
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1399-2012·2012-07-11

    Watson Loxapine Capsules Recalled for Outdated Patient Outsert

    Watson Laboratories is recalling 8,254 bottles of Loxapine Capsules 5mg because an outdated patient outsert was used during packaging.

    Product
    Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1403-2012·2012-07-11

    Watson Recalls Loxapine Succinate Capsules Due to Outdated Patient Outsert

    Watson Laboratories is recalling 7,262 bottles of Loxapine Succinate Capsules because an outdated patient outsert was used during packaging.

    Product
    Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1402-2012·2012-07-11

    Watson Recalls Loxapine Capsules Due to Outdated Patient Outsert

    Watson Laboratories is recalling 18,902 bottles of Loxapine 50mg capsules because an outdated patient outsert was used during packaging.

    Product
    LOXAPINE — LOXAPINE (LOXAPINE)
    Category
    Drug
    Distribution
    Distributed nationwide